PT2827840T - Solução oftálmica aquosa à base de ciclosporina a - Google Patents

Solução oftálmica aquosa à base de ciclosporina a

Info

Publication number
PT2827840T
PT2827840T PT137153383T PT13715338T PT2827840T PT 2827840 T PT2827840 T PT 2827840T PT 137153383 T PT137153383 T PT 137153383T PT 13715338 T PT13715338 T PT 13715338T PT 2827840 T PT2827840 T PT 2827840T
Authority
PT
Portugal
Prior art keywords
cyclosporin
ophthalmic solution
aqueous ophthalmic
based aqueous
solution
Prior art date
Application number
PT137153383T
Other languages
English (en)
Inventor
Muriaux Emmanuel
Mercier Fabrice
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46298539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2827840(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of PT2827840T publication Critical patent/PT2827840T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT137153383T 2012-03-22 2013-03-15 Solução oftálmica aquosa à base de ciclosporina a PT2827840T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261614218P 2012-03-22 2012-03-22
FR1252583A FR2988297B1 (fr) 2012-03-22 2012-03-22 Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur

Publications (1)

Publication Number Publication Date
PT2827840T true PT2827840T (pt) 2019-10-11

Family

ID=46298539

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137153383T PT2827840T (pt) 2012-03-22 2013-03-15 Solução oftálmica aquosa à base de ciclosporina a

Country Status (23)

Country Link
US (1) US8969305B2 (pt)
EP (1) EP2827840B1 (pt)
JP (1) JP6166341B2 (pt)
KR (1) KR102021633B1 (pt)
AR (1) AR090466A1 (pt)
BR (1) BR112014019141A8 (pt)
CA (1) CA2863000C (pt)
CL (1) CL2014002271A1 (pt)
CY (1) CY1122086T1 (pt)
DK (1) DK2827840T3 (pt)
ES (1) ES2746701T3 (pt)
FR (1) FR2988297B1 (pt)
HU (1) HUE045252T2 (pt)
LT (1) LT2827840T (pt)
MA (1) MA37297B1 (pt)
MX (1) MX350799B (pt)
PL (1) PL2827840T3 (pt)
PT (1) PT2827840T (pt)
RS (1) RS59324B1 (pt)
RU (1) RU2634267C2 (pt)
SI (1) SI2827840T1 (pt)
UA (1) UA115141C2 (pt)
WO (1) WO2013140071A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015093924A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Issac Vehículo para la administración de compuestos farmacéuticos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0558906A (ja) * 1991-09-06 1993-03-09 Sankyo Co Ltd シクロスポリン点眼製剤
JP3631490B2 (ja) * 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE60100866T2 (de) 2000-04-07 2004-07-29 Laboratoire Medidom S.A. Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
CN1127955C (zh) * 2000-07-07 2003-11-19 中山医科大学中山眼科中心 一种眼前段及眼表免疫相关性疾病治疗药物
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20060148686A1 (en) * 2004-12-30 2006-07-06 Bausch & Lomb Incorporated Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
US20080146497A1 (en) * 2006-07-25 2008-06-19 Graham Richard S Cyclosporin Compositions
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
EA019867B1 (ru) * 2007-10-08 2014-06-30 Фовея Фармасьютикалс Водные офтальмологические препараты
JP5668476B2 (ja) * 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
CN101842080A (zh) * 2007-11-01 2010-09-22 博士伦公司 非水的水混溶性物质作为药物递送的载体
CA2710843A1 (en) * 2008-01-04 2009-07-16 Alcon Pharmaceuticals Ltd. Stable aqueous cyclosporin compositions
CN101244035A (zh) * 2008-02-21 2008-08-20 南京医科大学附属南京第一医院 一种环孢菌素a眼用乳剂制剂及其制备方法
KR20120022574A (ko) * 2010-07-30 2012-03-12 주식회사종근당 사이클로스포린 에이 함유 점안제 조성물

Also Published As

Publication number Publication date
FR2988297B1 (fr) 2014-03-28
CA2863000A1 (fr) 2013-09-26
RU2014134741A (ru) 2016-03-20
JP2015510921A (ja) 2015-04-13
KR102021633B1 (ko) 2019-09-16
MA37297A1 (fr) 2016-05-31
US8969305B2 (en) 2015-03-03
AR090466A1 (es) 2014-11-12
KR20140136932A (ko) 2014-12-01
RU2634267C2 (ru) 2017-10-24
BR112014019141A2 (pt) 2017-06-20
SI2827840T1 (sl) 2019-11-29
MA37297B1 (fr) 2017-01-31
US20130267472A1 (en) 2013-10-10
RS59324B1 (sr) 2019-10-31
UA115141C2 (uk) 2017-09-25
LT2827840T (lt) 2019-10-10
HUE045252T2 (hu) 2019-12-30
WO2013140071A1 (fr) 2013-09-26
MX350799B (es) 2017-09-25
CA2863000C (fr) 2020-04-21
CL2014002271A1 (es) 2014-11-03
BR112014019141A8 (pt) 2017-07-11
DK2827840T3 (da) 2019-09-30
CY1122086T1 (el) 2020-11-25
MX2014010270A (es) 2015-01-14
FR2988297A1 (fr) 2013-09-27
PL2827840T3 (pl) 2019-12-31
JP6166341B2 (ja) 2017-07-19
ES2746701T3 (es) 2020-03-06
EP2827840A1 (fr) 2015-01-28
EP2827840B1 (fr) 2019-08-28

Similar Documents

Publication Publication Date Title
HK1202427A1 (en) Ophthalmological vehicle system
EP2868552A4 (en) CONSTRUCTION STRUCTURE FOR VEHICLE CABIN
EP2856999A4 (en) EXPOSURE PREVENTION CAP
EP2812777A4 (en) STRING COMPLETION
SG11201405799TA (en) Ophthalmic solution comprising diquafosol
IL237591A0 (en) Electrode pad kit
AU345615S (en) Electrode
EP2903496A4 (en) GUIDING ARRANGEMENT OF THE LOOK
EP2868741A4 (en) AQUEOUS TREATMENT LIQUID
EP2902462A4 (en) STRUCTURE BODY
EP2679167A4 (en) sonographer
HK1210589A1 (en) Aqueous liquid medicine
SG10201801458VA (en) Ophthalmic solution
HK1207964A1 (en) Aqueous ophthalmic composition
HK1200109A1 (en) Ophthalmic composition
ZA201502355B (en) Fast dissolving ocular insert
HK1200113A1 (en) Ophthalmic composition
PL2827743T3 (pl) Element z zębami
EP2696876A4 (en) AQUEOUS OPHTHALMIC COMPOSITION
HK1192140A1 (zh) 水性眼科用組合物
PT2827840T (pt) Solução oftálmica aquosa à base de ciclosporina a
IL234194B (en) Cyclosporin a-based aqueous ophthalmic solution
GB2519923B (en) Ophthalmic surgery
EP2800573A4 (en) OPHTHALMIC COMPOSITION
ZA201306201B (en) Vision assistance assembly